144 related articles for article (PubMed ID: 10515387)
1. In vivo T cell depletion in miniature swine using the swine CD3 immunotoxin, pCD3-CRM9.
Huang CA; Yamada K; Murphy MC; Shimizu A; Colvin RB; Neville DM; Sachs DH
Transplantation; 1999 Sep; 68(6):855-60. PubMed ID: 10515387
[TBL] [Abstract][Full Text] [Related]
2. Neuropathy in miniature swine after administration of the mutant diphtheria toxin-based immunotoxin, pCD3-CRM9.
Gargollo P; Yamada K; Esnaola N; Fuchimoto Y; Newell KL; Sachs DH; Huang CA
Transplantation; 2001 Sep; 72(5):818-22. PubMed ID: 11571443
[TBL] [Abstract][Full Text] [Related]
3. Development of a diphtheria toxin based antiporcine CD3 recombinant immunotoxin.
Wang Z; Duran-Struuck R; Crepeau R; Matar A; Hanekamp I; Srinivasan S; Neville DM; Sachs DH; Huang CA
Bioconjug Chem; 2011 Oct; 22(10):2014-20. PubMed ID: 21866954
[TBL] [Abstract][Full Text] [Related]
4. A new reagent for the induction of T-cell depletion, anti-CD3-CRM9.
Neville DM; Scharff J; Hu HZ; Rigaut K; Shiloach J; Slingerland W; Jonker M
J Immunother Emphasis Tumor Immunol; 1996 Mar; 19(2):85-92. PubMed ID: 8732691
[TBL] [Abstract][Full Text] [Related]
5. Treatment with immunotoxin.
Knechtle SJ
Philos Trans R Soc Lond B Biol Sci; 2001 May; 356(1409):681-9. PubMed ID: 11375071
[TBL] [Abstract][Full Text] [Related]
6. Recombinant anti-monkey CD3 immunotoxin depletes peripheral lymph node T lymphocytes more effectively than rabbit anti-thymocyte globulin in naïve baboons.
Wamala I; Matar AJ; Farkash E; Wang Z; Huang CA; Sachs DH
Transpl Immunol; 2013 Dec; 29(1-4):60-3. PubMed ID: 24157659
[TBL] [Abstract][Full Text] [Related]
7. Effect of pre-existing anti-diphtheria toxin antibodies on T cell depletion levels following diphtheria toxin-based recombinant anti-monkey CD3 immunotoxin treatment.
Matar AJ; Pathiraja V; Wang Z; Duran-Struuck R; Gusha A; Crepeau R; Tasaki M; Sachs DH; Huang CA
Transpl Immunol; 2012 Aug; 27(1):52-4. PubMed ID: 22676970
[TBL] [Abstract][Full Text] [Related]
8. T-cell depletion and graft survival induced by anti-human CD3 immunotoxins in human CD3epsilon transgenic mice.
Weetall M; Digan ME; Hugo R; Mathew S; Hopf C; Tart-Risher N; Zhang J; Shi V; Fu F; Hammond-McKibben D; West S; Brack R; Brinkmann V; Bergman R; Neville D; Lake P
Transplantation; 2002 May; 73(10):1658-66. PubMed ID: 12042656
[TBL] [Abstract][Full Text] [Related]
9. Characterization of a monoclonal anti-porcine CD3 antibody.
Huang CA; Lorf T; Arn JS; Koo GC; Blake T; Sachs DH
Xenotransplantation; 1999 Aug; 6(3):201-12. PubMed ID: 10503787
[TBL] [Abstract][Full Text] [Related]
10. Porcine Treg depletion with a novel diphtheria toxin-based anti-human CCR4 immunotoxin.
Wang Z; Navarro-Alvarez N; Shah JA; Zhang H; Huang Q; Zheng Q; Madsen JC; Sachs DH; Huang CA; Wang Z
Vet Immunol Immunopathol; 2016 Dec; 182():150-158. PubMed ID: 27863545
[TBL] [Abstract][Full Text] [Related]
11. Improved binding of a bivalent single-chain immunotoxin results in increased efficacy for in vivo T-cell depletion.
Thompson J; Stavrou S; Weetall M; Hexham JM; Digan ME; Wang Z; Woo JH; Yu Y; Mathias A; Liu YY; Ma S; Gordienko I; Lake P; Neville DM
Protein Eng; 2001 Dec; 14(12):1035-41. PubMed ID: 11809934
[TBL] [Abstract][Full Text] [Related]
12. The effect of anti-CD3-immunotoxin on T lymphocyte function in vitro.
Meng G; Jiang Y; Hubbard W; Thomas JM
Transpl Immunol; 1998 Mar; 6(1):53-9. PubMed ID: 9640629
[TBL] [Abstract][Full Text] [Related]
13. Immunotoxin FN18-CRM9 induces stronger T cell signaling than unconjugated monoclonal antibody FN18.
Hamawy MM; Tsuchida M; Cho CS; Manthei ER; Fechner JH; Knechtle SJ
Transplantation; 2001 Aug; 72(3):496-503. PubMed ID: 11502982
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of tolerance induced by an immunotoxin against CD3 epsilon in a rhesus kidney allograft model.
Fechner JH; Vargo DJ; Geissler EK; Wang J; Neville DM; Knechtle SJ
Transplant Proc; 1997; 29(1-2):1158. PubMed ID: 9123249
[No Abstract] [Full Text] [Related]
15. Stable mixed chimerism and tolerance using a nonmyeloablative preparative regimen in a large-animal model.
Huang CA; Fuchimoto Y; Scheier-Dolberg R; Murphy MC; Neville DM; Sachs DH
J Clin Invest; 2000 Jan; 105(2):173-81. PubMed ID: 10642595
[TBL] [Abstract][Full Text] [Related]
16. Phenotypic and functional analysis of T-cell recovery after anti-CD3 immunotoxin treatment for tolerance induction in rhesus macaques.
Hubbard WJ; Moore JK; Contreras JL; Smyth CA; Chen ZW; Lobashevsky AL; Nagata K; Neville DM; Thomas JM
Hum Immunol; 2001 May; 62(5):479-87. PubMed ID: 11334671
[TBL] [Abstract][Full Text] [Related]
17. Genetic construction and characterization of an anti-monkey CD3 single-chain immunotoxin with a truncated diphtheria toxin.
Ma S; Hu H; Thompson J; Stavrou S; Scharff J; Neville DM
Bioconjug Chem; 1997; 8(5):695-701. PubMed ID: 9327133
[TBL] [Abstract][Full Text] [Related]
18. In vivo T-cell ablation by a holo-immunotoxin directed at human CD3.
Neville DM; Scharff J; Srinivasachar K
Proc Natl Acad Sci U S A; 1992 Apr; 89(7):2585-9. PubMed ID: 1372981
[TBL] [Abstract][Full Text] [Related]
19. Analysis of primate renal allografts after T-cell depletion with anti-CD3-CRM9.
Armstrong N; Buckley P; Oberley T; Fechner J; Dong Y; Hong X; Kirk A; Neville D; Knechtle S
Transplantation; 1998 Jul; 66(1):5-13. PubMed ID: 9679815
[TBL] [Abstract][Full Text] [Related]
20. An anti-CD3 single-chain immunotoxin with a truncated diphtheria toxin avoids inhibition by pre-existing antibodies in human blood.
Thompson J; Hu H; Scharff J; Neville DM
J Biol Chem; 1995 Nov; 270(47):28037-41. PubMed ID: 7499288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]